Companion Animal Diagnostics Market (By Technology: Clinical Biochemistry, Clinical Chemistry Analyzers, Glucose Monitoring, Immunodiagnostics, Hematology, Molecular Diagnostics, Urinalysis, Others; By Animal Type: Dogs, Cats, Equine; By Application: Clinical Pathology, Bacteriology, Parasitology, Others; By End-use: Laboratories, Veterinary Hospitals & Clinics, Point-of-Care/in-House Testing, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Companion Animal Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Companion Animal Diagnostics Market, by Technology, 2024-2033
8.1.1. Clinical Biochemistry
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Clinical Chemistry Analyzers
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Glucose Monitoring
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Immunodiagnostics
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Hematology
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Molecular Diagnostics
8.1.6.1. Market Revenue and Forecast (2021-2033)
8.1.7. Urinalysis
8.1.7.1. Market Revenue and Forecast (2021-2033)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2033)
9.1. Companion Animal Diagnostics Market, by Animal Type, 2024-2033
9.1.1. Dogs
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Cats
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Equine
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. Companion Animal Diagnostics Market, by Application, 2024-2033
10.1.1. Clinical Pathology
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Bacteriology
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Parasitology
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2021-2033)
11.1. Companion Animal Diagnostics Market, by End-use, 2024-2033
11.1.1. Laboratories
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Veterinary Hospitals & Clinics
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Point-of-Care/in-House Testing
11.1.3.1. Market Revenue and Forecast (2021-2033)
11.1.4. Research Institutes and Universities
11.1.4.1. Market Revenue and Forecast (2021-2033)
12.1. North America
12.1.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.1.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Forecast, by End-use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.2.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.3.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.4.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Forecast, by End-use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Technology (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Forecast, by End-use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Technology (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Forecast, by End-use (2021-2033)
13.1. IDEXX Laboratories, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Zoetis Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Heska Corporation
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Thermo Fisher Scientific, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Abaxis, Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Virbac SA
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. VCA, Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. IDVet
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NEOGEN Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. bioMérieux SA
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample